INVOKAMET XR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is Canagliflozin; Metformin Hydrochloride.
Product ID | 50458-942_2276e4f3-2afe-48ac-b293-fd4befeff063 |
NDC | 50458-942 |
Product Type | Human Prescription Drug |
Proprietary Name | INVOKAMET XR |
Generic Name | Canagliflozin And Metformin Hydrochloride |
Dosage Form | Tablet, Film Coated, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2016-09-20 |
Marketing Category | NDA / NDA |
Application Number | NDA205879 |
Labeler Name | Janssen Pharmaceuticals, Inc. |
Substance Name | CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
Active Ingredient Strength | 150 mg/1; mg/1 |
Pharm Classes | Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Biguanide [EPC],Biguanides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2016-09-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA205879 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-09-20 |
Marketing Category | NDA |
Application Number | NDA205879 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-09-20 |
Marketing End Date | 2020-02-07 |
Ingredient | Strength |
---|---|
CANAGLIFLOZIN | 150 mg/1 |
SPL SET ID: | 6868666b-c25e-40d1-9d1f-306bbe9390c1 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
50458-940 | INVOKAMET XR | canagliflozin and metformin hydrochloride |
50458-941 | INVOKAMET XR | canagliflozin and metformin hydrochloride |
50458-942 | INVOKAMET XR | canagliflozin and metformin hydrochloride |
50458-943 | INVOKAMET XR | canagliflozin and metformin hydrochloride |
50458-540 | INVOKAMET | canagliflozin and metformin hydrochloride |
50458-541 | INVOKAMET | canagliflozin and metformin hydrochloride |
50458-542 | INVOKAMET | canagliflozin and metformin hydrochloride |
50458-543 | INVOKAMET | canagliflozin and metformin hydrochloride |
63629-8260 | INVOKAMET | canagliflozin and metformin hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
INVOKAMET XR 86277042 5134045 Live/Registered |
JOHNSON & JOHNSON 2014-05-09 |